Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 4 Open-market buy Pres&Co-Head Bausch&Lomb/Int'l bought 25,440 shares at $22.96 ($584,018)
  2. 4 Grant or award Director acquired 5,832 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale EVP AND GENERAL COUNSEL sold 19,946 shares at an average $24.98 ($498,302)
  5. 4 Grant or award Director acquired 1,217 shares (grant or award)
  6. 4 Grant or award Director acquired 1,460 shares (grant or award)
  7. 4 Grant or award Director acquired 1,071 shares (grant or award)
  8. 4 Grant or award Director acquired 1,217 shares (grant or award)
  9. 4/A Shares withheld for taxes Pres&Co-Head Bausch&Lomb/Int'l gave up 6,604 shares (to pay taxes)
  10. 4 Open-market buy Director bought 125,000 shares at $23.96 ($2,995,000)
  11. 4 Open-market buy EVP and CFO bought 10,000 shares at $22.61 ($226,100)
  12. 4 Open-market buy CHAIRMAN & CEO bought 30,000 shares at $22.32 ($669,600)
  13. 4 Shares withheld for taxes EVP and CFO gave up 24,626 shares (to pay taxes)
  14. 4 Shares withheld for taxes Pres&Co-Head Bausch&Lomb/Int'l gave up 5,501 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP AND GENERAL COUNSEL gave up 7,779 shares (to pay taxes)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market buy Director bought 10,000 shares at $21.80 ($218,000)
  19. 4 Grant or award Director acquired 1,183 shares (grant or award)
  20. 4 Grant or award Director acquired 1,613 shares (grant or award)

Page 24 of 61 · 1,214 filings